US Stock MarketDetailed Quotes

Dr. Reddy's Laboratories (RDY)

Watchlist
  • 13.720
  • +0.080+0.59%
Close May 1 15:59 ET
  • 13.759
  • +0.039+0.29%
Post 20:01 ET
11.42BMarket Cap19.16P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Dr. Reddy's Laboratories (RDY) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Dec 31, 2025
(Q2)Sep 30, 2025
(Q1)Jun 30, 2025
(FY)Mar 31, 2025
(Q4)Mar 31, 2025
(Q3)Dec 31, 2024
(Q2)Sep 30, 2024
(Q1)Jun 30, 2024
(FY)Mar 31, 2024
(Q4)Mar 31, 2024
Total revenue
4.41%87.27B
9.84%88.05B
11.37%85.45B
16.61%325.54B
20.09%85.06B
15.85%83.59B
16.51%80.16B
13.87%76.73B
13.54%279.16B
12.49%70.83B
Operating revenue
4.41%87.27B
9.84%88.05B
11.37%85.45B
16.61%325.54B
20.09%85.06B
15.85%83.59B
16.51%80.16B
13.87%76.73B
13.54%279.16B
12.49%70.83B
Cost of revenue
17.17%40.46B
23.21%39.91B
21.20%36.83B
16.92%135.11B
28.79%37.8B
15.32%34.53B
13.92%32.39B
9.17%30.38B
8.47%115.56B
8.81%29.35B
Gross profit
-4.58%46.81B
0.78%48.14B
4.93%48.63B
16.39%190.43B
13.93%47.26B
16.23%49.05B
18.33%47.77B
17.17%46.34B
17.41%163.61B
15.24%41.48B
Operating expense
7.03%32.48B
1.85%30.27B
10.36%31.79B
20.46%118.41B
6.06%29.92B
19.95%30.34B
29.90%29.72B
31.48%28.8B
22.43%98.3B
22.96%28.21B
Selling and administrative expenses
11.61%26.92B
14.90%26.44B
10.98%23.18B
21.59%93.87B
17.48%24.06B
19.23%24.12B
22.41%23.01B
17.99%20.89B
13.49%77.2B
13.81%20.48B
-General and administrative expense
----
----
10.98%23.18B
----
----
----
----
--20.89B
----
----
Research and development costs
-7.64%6.15B
-14.70%6.2B
0.82%6.24B
19.70%27.38B
5.54%7.26B
19.64%6.66B
33.49%7.27B
24.26%6.19B
18.02%22.87B
28.16%6.88B
Depreciation amortization depletion
----
----
36.70%2.47B
----
----
----
----
--1.8B
----
----
-Depreciation and amortization
----
----
36.70%2.47B
----
----
----
----
--1.8B
----
----
Other operating expenses
-37.12%-591M
-326.90%-2.37B
-29.27%-106M
-59.77%-2.84B
-264.08%-1.4B
13.10%-431M
59.23%-554M
89.49%-82M
75.06%-1.78B
302.86%852M
Operating profit
-23.40%14.33B
-0.99%17.87B
-3.99%16.84B
10.27%72.01B
30.65%17.35B
10.66%18.71B
3.20%18.05B
-0.60%17.54B
10.59%65.31B
1.68%13.28B
Net non-operating interest income expense
-29.82%-148M
105.43%5M
104.11%298M
-126.81%-152M
-270.37%-92M
-160.32%-114M
-125.14%-92M
-81.38%146M
328.63%567M
-55.00%54M
Non-operating interest income
13.07%796M
37.14%912M
51.61%1.13B
17.52%2.68B
-12.83%564M
20.75%704M
-7.51%665M
--744M
93.05%2.28B
36.50%647M
Non-operating interest expense
15.40%944M
19.82%907M
38.80%830M
65.34%2.83B
10.62%656M
107.61%818M
114.45%757M
--598M
19.82%1.71B
67.51%593M
Total other finance cost
----
----
----
----
----
----
----
-6.76%-837M
----
----
Other net income (expense)
742.57%1.25B
-60.63%478M
68.31%1.91B
-17.90%4.92B
4.25%2.8B
-87.26%148M
-5.38%1.21B
3,440.63%1.13B
284.05%6B
3,431.58%2.68B
Gain on sale of security
1,300.00%1.32B
-53.31%769M
84.08%1.27B
42.28%4.88B
152.48%2.44B
-87.86%94M
91.73%1.65B
--691M
10.51%3.43B
42.56%968M
Earnings from equity interest
-45.24%23M
3.28%63M
-96.61%2M
47.62%217M
57.14%55M
55.56%42M
45.24%61M
37.21%59M
-60.27%147M
-53.95%35M
Special income (charges)
-866.67%-92M
28.34%-354M
-433.33%-40M
-107.06%-171M
-82.21%299M
-96.68%12M
-229.32%-494M
209.09%12M
226.75%2.42B
347.57%1.68B
-Less:Impairment of capital assets
6,875.00%271M
-28.35%662M
--0
56,333.33%1.69B
543.93%768M
-103.64%-4M
1,580.00%924M
-54.55%5M
-99.57%3M
-132.04%-173M
-Less:Other special charges
----
----
----
----
----
----
----
----
---1.52B
----
-Write off
----
----
----
----
----
----
----
--5M
----
----
-Gain on sale of property,plant,equipment
2,137.50%179M
-28.37%308M
-335.29%-40M
69.11%1.52B
6,768.75%1.07B
-98.30%8M
-1.60%430M
--17M
174.32%900M
88.49%-16M
Other non- operating income (expenses)
----
----
81.40%673M
----
----
----
----
--371M
----
----
Income before tax
-17.68%15.43B
-4.26%18.35B
1.20%19.05B
6.84%76.78B
25.21%20.05B
2.66%18.74B
0.17%19.17B
1.94%18.82B
19.06%71.87B
20.83%16.02B
Income tax
-24.89%3.53B
-29.03%4.08B
1.02%4.95B
20.72%19.54B
41.96%4.18B
5.28%4.7B
32.72%5.75B
10.43%4.9B
5.79%16.19B
-19.57%2.95B
Net income
-15.26%11.9B
6.36%14.27B
1.26%14.1B
2.80%57.25B
21.44%15.87B
1.81%14.04B
-9.36%13.42B
-0.75%13.92B
23.56%55.68B
36.26%13.07B
Net income continuous Operations
-15.26%11.9B
6.36%14.27B
1.26%14.1B
2.80%57.25B
21.44%15.87B
1.81%14.04B
-9.36%13.42B
-0.75%13.92B
23.56%55.68B
36.26%13.07B
Minority interest income
-112.63%-202M
-112.06%-104M
-82M
701M
-66M
-95M
862M
0
0
Net income attributable to the parent company
-14.40%12.1B
14.49%14.37B
1.85%14.18B
1.54%56.54B
21.94%15.94B
2.49%14.13B
-15.18%12.55B
-0.75%13.92B
23.56%55.68B
36.26%13.07B
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-14.40%12.1B
14.49%14.37B
1.85%14.18B
1.54%56.54B
21.94%15.94B
2.49%14.13B
-15.18%12.55B
-0.75%13.92B
23.56%55.68B
36.26%13.07B
Basic earnings per share
-14.33%14.53
14.53%17.26
1.91%17.04
1.42%67.88
21.54%19.12
2.42%16.96
323.55%15.07
-0.93%16.72
23.31%66.93
36.11%15.732
Diluted earnings per share
-14.29%14.52
14.62%17.25
1.98%17.02
1.47%67.78
21.61%19.1
2.42%16.94
323.70%15.05
-0.91%16.69
23.32%66.8
36.15%15.706
Dividend per share
0
0.58%8.0206
0
-0.38%7.9746
0
0
7.9746
0
8.0052
0
Currency Unit
INR
INR
INR
INR
INR
INR
INR
INR
INR
INR
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Dec 31, 2025(Q2)Sep 30, 2025(Q1)Jun 30, 2025(FY)Mar 31, 2025(Q4)Mar 31, 2025(Q3)Dec 31, 2024(Q2)Sep 30, 2024(Q1)Jun 30, 2024(FY)Mar 31, 2024(Q4)Mar 31, 2024
Total revenue 4.41%87.27B9.84%88.05B11.37%85.45B16.61%325.54B20.09%85.06B15.85%83.59B16.51%80.16B13.87%76.73B13.54%279.16B12.49%70.83B
Operating revenue 4.41%87.27B9.84%88.05B11.37%85.45B16.61%325.54B20.09%85.06B15.85%83.59B16.51%80.16B13.87%76.73B13.54%279.16B12.49%70.83B
Cost of revenue 17.17%40.46B23.21%39.91B21.20%36.83B16.92%135.11B28.79%37.8B15.32%34.53B13.92%32.39B9.17%30.38B8.47%115.56B8.81%29.35B
Gross profit -4.58%46.81B0.78%48.14B4.93%48.63B16.39%190.43B13.93%47.26B16.23%49.05B18.33%47.77B17.17%46.34B17.41%163.61B15.24%41.48B
Operating expense 7.03%32.48B1.85%30.27B10.36%31.79B20.46%118.41B6.06%29.92B19.95%30.34B29.90%29.72B31.48%28.8B22.43%98.3B22.96%28.21B
Selling and administrative expenses 11.61%26.92B14.90%26.44B10.98%23.18B21.59%93.87B17.48%24.06B19.23%24.12B22.41%23.01B17.99%20.89B13.49%77.2B13.81%20.48B
-General and administrative expense --------10.98%23.18B------------------20.89B--------
Research and development costs -7.64%6.15B-14.70%6.2B0.82%6.24B19.70%27.38B5.54%7.26B19.64%6.66B33.49%7.27B24.26%6.19B18.02%22.87B28.16%6.88B
Depreciation amortization depletion --------36.70%2.47B------------------1.8B--------
-Depreciation and amortization --------36.70%2.47B------------------1.8B--------
Other operating expenses -37.12%-591M-326.90%-2.37B-29.27%-106M-59.77%-2.84B-264.08%-1.4B13.10%-431M59.23%-554M89.49%-82M75.06%-1.78B302.86%852M
Operating profit -23.40%14.33B-0.99%17.87B-3.99%16.84B10.27%72.01B30.65%17.35B10.66%18.71B3.20%18.05B-0.60%17.54B10.59%65.31B1.68%13.28B
Net non-operating interest income expense -29.82%-148M105.43%5M104.11%298M-126.81%-152M-270.37%-92M-160.32%-114M-125.14%-92M-81.38%146M328.63%567M-55.00%54M
Non-operating interest income 13.07%796M37.14%912M51.61%1.13B17.52%2.68B-12.83%564M20.75%704M-7.51%665M--744M93.05%2.28B36.50%647M
Non-operating interest expense 15.40%944M19.82%907M38.80%830M65.34%2.83B10.62%656M107.61%818M114.45%757M--598M19.82%1.71B67.51%593M
Total other finance cost -----------------------------6.76%-837M--------
Other net income (expense) 742.57%1.25B-60.63%478M68.31%1.91B-17.90%4.92B4.25%2.8B-87.26%148M-5.38%1.21B3,440.63%1.13B284.05%6B3,431.58%2.68B
Gain on sale of security 1,300.00%1.32B-53.31%769M84.08%1.27B42.28%4.88B152.48%2.44B-87.86%94M91.73%1.65B--691M10.51%3.43B42.56%968M
Earnings from equity interest -45.24%23M3.28%63M-96.61%2M47.62%217M57.14%55M55.56%42M45.24%61M37.21%59M-60.27%147M-53.95%35M
Special income (charges) -866.67%-92M28.34%-354M-433.33%-40M-107.06%-171M-82.21%299M-96.68%12M-229.32%-494M209.09%12M226.75%2.42B347.57%1.68B
-Less:Impairment of capital assets 6,875.00%271M-28.35%662M--056,333.33%1.69B543.93%768M-103.64%-4M1,580.00%924M-54.55%5M-99.57%3M-132.04%-173M
-Less:Other special charges -----------------------------------1.52B----
-Write off ------------------------------5M--------
-Gain on sale of property,plant,equipment 2,137.50%179M-28.37%308M-335.29%-40M69.11%1.52B6,768.75%1.07B-98.30%8M-1.60%430M--17M174.32%900M88.49%-16M
Other non- operating income (expenses) --------81.40%673M------------------371M--------
Income before tax -17.68%15.43B-4.26%18.35B1.20%19.05B6.84%76.78B25.21%20.05B2.66%18.74B0.17%19.17B1.94%18.82B19.06%71.87B20.83%16.02B
Income tax -24.89%3.53B-29.03%4.08B1.02%4.95B20.72%19.54B41.96%4.18B5.28%4.7B32.72%5.75B10.43%4.9B5.79%16.19B-19.57%2.95B
Net income -15.26%11.9B6.36%14.27B1.26%14.1B2.80%57.25B21.44%15.87B1.81%14.04B-9.36%13.42B-0.75%13.92B23.56%55.68B36.26%13.07B
Net income continuous Operations -15.26%11.9B6.36%14.27B1.26%14.1B2.80%57.25B21.44%15.87B1.81%14.04B-9.36%13.42B-0.75%13.92B23.56%55.68B36.26%13.07B
Minority interest income -112.63%-202M-112.06%-104M-82M701M-66M-95M862M00
Net income attributable to the parent company -14.40%12.1B14.49%14.37B1.85%14.18B1.54%56.54B21.94%15.94B2.49%14.13B-15.18%12.55B-0.75%13.92B23.56%55.68B36.26%13.07B
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -14.40%12.1B14.49%14.37B1.85%14.18B1.54%56.54B21.94%15.94B2.49%14.13B-15.18%12.55B-0.75%13.92B23.56%55.68B36.26%13.07B
Basic earnings per share -14.33%14.5314.53%17.261.91%17.041.42%67.8821.54%19.122.42%16.96323.55%15.07-0.93%16.7223.31%66.9336.11%15.732
Diluted earnings per share -14.29%14.5214.62%17.251.98%17.021.47%67.7821.61%19.12.42%16.94323.70%15.05-0.91%16.6923.32%66.836.15%15.706
Dividend per share 00.58%8.02060-0.38%7.9746007.974608.00520
Currency Unit INRINRINRINRINRINRINRINRINRINR
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +17.90%
Sample Name
Sample Code
 +13.59%
Sample Name
Sample Code
 +12.81%
4
VanEck Oil Services ETF
OIH
+11.45%
5
United Sts 12 Month Oil Fd Lp Unit Ben Int
USL
+9.96%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +11.87%
Sample Name
Sample Code
 +6.69%
Sample Name
Sample Code
 +6.27%
4
KE Holdings
BEKE
+5.44%
5
New Oriental
EDU
+4.10%
View More
Middle East conflict spreads to the stock market! How should investors respond?
On May 1, the more than two-month-long military conflict involving the US, Israel, and Iran will reach a legal milestone, potentially increa Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -